グアイフェネシン（API）のグローバル市場2021

• 英文タイトル：Global Guaifenesin (API) Sales Market Report 2021

• レポートコード：QAF27707
• 出版社/出版日：QYResearch / 2021年4月13日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、147ページ
• 納品方法：Eメール（即日納品）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本市場調査資料では、世界のグアイフェネシン（API）市場について種類別（98%-99%、>99%）、用途別（医薬品、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・グアイフェネシン（API）市場の概要
・世界の主要地域別グアイフェネシン（API）市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のグアイフェネシン（API）市場規模2016-2021：種類別（98%-99%、>99%）
・世界のグアイフェネシン（API）市場予測2012-2027：種類別（98%-99%、>99%）
・世界のグアイフェネシン（API）市場規模2016-2021：用途別（医薬品、その他）
・世界のグアイフェネシン（API）市場予測2012-2027：用途別（医薬品、その他）
・グアイフェネシン（API）のアメリカ市場規模と予測2016-2021
・グアイフェネシン（API）のヨーロッパ市場規模と予測2016-2021
・グアイフェネシン（API）の中国市場規模と予測2016-2021
・グアイフェネシン（API）の日本市場規模と予測2016-2021
・グアイフェネシン（API）の東南アジア市場規模と予測2016-2021
・グアイフェネシン（API）のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報：事業概要・売上・企業動向
（Granules、Synthokem Labs、Haizhou Pharma、Yuan Cheng Group、Stellar Chemical、Seven Star Pharma、Gennex Lab、Iwaki Seiyaku、Pan Drugs、Delta Synthetic、Smart Pharm）
・グアイフェネシン（API）の製造コスト分析
・販売チャネル、流通業者、顧客
・グアイフェネシン（API）の市場動向・機会・課題
・調査の結論

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
There are mainly two-type product of Guaifenesin (API) market: >99% and 98%-99%. In 2019, >99% type accounted for a share of over 70% in the global Guaifenesin (API) market.
Geographically, the global Guaifenesin (API) sales market has been segmented into North America, Europe, Asia-Pacific, South America and Middle East & Africa. The North America held the largest share in the global market, its revenue of global market exceeds 38% in 2019.
The leading manufactures mainly are Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, Seven Star Pharma, Gennex Lab, Iwaki Seiyaku, Pan Drugs, Delta Synthetic, Smart Pharm, etc. Granules is the largest manufacturer; its revenue of global market exceeds 26% in 2019.

Market Analysis and Insights: Global Guaifenesin (API) Market
The global Guaifenesin (API) market was valued at US$ 74 in 2020 and will reach US$ 94 million by the end of 2027, growing at a CAGR of 3.9% during 2022-2027.

Global Guaifenesin (API) Scope and Market Size
The global Guaifenesin (API) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Guaifenesin (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
98%-99%
>99%

Segment by Application
Pharmaceuticals
Others

The Guaifenesin (API) market is analysed and market size information is provided by regions (countries). Segment by Application, the Guaifenesin (API) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm

レポート目次

1 Guaifenesin (API) Market Overview
1.1 Guaifenesin (API) Product Scope
1.2 Guaifenesin (API) Segment by Type
1.2.1 Global Guaifenesin (API) Sales by Type (2016 & 2021 & 2027)
1.2.2 98%-99%
1.2.3 >99%
1.3 Guaifenesin (API) Segment by Application
1.3.1 Global Guaifenesin (API) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Guaifenesin (API) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Guaifenesin (API) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Guaifenesin (API) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Guaifenesin (API) Price Trends (2016-2027)

2 Guaifenesin (API) Estimates and Forecasts by Region
2.1 Global Guaifenesin (API) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Guaifenesin (API) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Guaifenesin (API) Sales Market Share by Region (2016-2021)
2.2.2 Global Guaifenesin (API) Revenue Market Share by Region (2016-2021)
2.3 Global Guaifenesin (API) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Guaifenesin (API) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Guaifenesin (API) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Guaifenesin (API) Estimates and Projections (2016-2027)
2.4.2 Europe Guaifenesin (API) Estimates and Projections (2016-2027)
2.4.3 China Guaifenesin (API) Estimates and Projections (2016-2027)
2.4.4 Japan Guaifenesin (API) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Guaifenesin (API) Estimates and Projections (2016-2027)
2.4.6 India Guaifenesin (API) Estimates and Projections (2016-2027)
3 Global Guaifenesin (API) Competition Landscape by Players
3.1 Global Top Guaifenesin (API) Players by Sales (2016-2021)
3.2 Global Top Guaifenesin (API) Players by Revenue (2016-2021)
3.3 Global Guaifenesin (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Guaifenesin (API) as of 2020)
3.4 Global Guaifenesin (API) Average Price by Company (2016-2021)
3.5 Manufacturers Guaifenesin (API) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Guaifenesin (API) Market Size by Type
4.1 Global Guaifenesin (API) Historic Market Review by Type (2016-2021)
4.1.1 Global Guaifenesin (API) Sales Market Share by Type (2016-2021)
4.1.2 Global Guaifenesin (API) Revenue Market Share by Type (2016-2021)
4.1.3 Global Guaifenesin (API) Price by Type (2016-2021)
4.2 Global Guaifenesin (API) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Guaifenesin (API) Sales Forecast by Type (2022-2027)
4.2.2 Global Guaifenesin (API) Revenue Forecast by Type (2022-2027)
4.2.3 Global Guaifenesin (API) Price Forecast by Type (2022-2027)
5 Global Guaifenesin (API) Market Size by Application
5.1 Global Guaifenesin (API) Historic Market Review by Application (2016-2021)
5.1.1 Global Guaifenesin (API) Sales Market Share by Application (2016-2021)
5.1.2 Global Guaifenesin (API) Revenue Market Share by Application (2016-2021)
5.1.3 Global Guaifenesin (API) Price by Application (2016-2021)
5.2 Global Guaifenesin (API) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Guaifenesin (API) Sales Forecast by Application (2022-2027)
5.2.2 Global Guaifenesin (API) Revenue Forecast by Application (2022-2027)
5.2.3 Global Guaifenesin (API) Price Forecast by Application (2022-2027)

6 North America Guaifenesin (API) Market Facts & Figures
6.1 North America Guaifenesin (API) Sales by Company
6.1.1 North America Guaifenesin (API) Sales by Company (2016-2021)
6.1.2 North America Guaifenesin (API) Revenue by Company (2016-2021)
6.2 North America Guaifenesin (API) Sales Breakdown by Type
6.2.1 North America Guaifenesin (API) Sales Breakdown by Type (2016-2021)
6.2.2 North America Guaifenesin (API) Sales Breakdown by Type (2022-2027)
6.3 North America Guaifenesin (API) Sales Breakdown by Application
6.3.1 North America Guaifenesin (API) Sales Breakdown by Application (2016-2021)
6.3.2 North America Guaifenesin (API) Sales Breakdown by Application (2022-2027)

7 Europe Guaifenesin (API) Market Facts & Figures
7.1 Europe Guaifenesin (API) Sales by Company
7.1.1 Europe Guaifenesin (API) Sales by Company (2016-2021)
7.1.2 Europe Guaifenesin (API) Revenue by Company (2016-2021)
7.2 Europe Guaifenesin (API) Sales Breakdown by Type
7.2.1 Europe Guaifenesin (API) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Guaifenesin (API) Sales Breakdown by Type (2022-2027)
7.3 Europe Guaifenesin (API) Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Guaifenesin (API) Market Facts & Figures
8.1 China Guaifenesin (API) Sales by Company
8.1.1 China Guaifenesin (API) Sales by Company (2016-2021)
8.1.2 China Guaifenesin (API) Revenue by Company (2016-2021)
8.2 China Guaifenesin (API) Sales Breakdown by Type
8.2.1 China Guaifenesin (API) Sales Breakdown by Type (2016-2021)
8.2.2 China Guaifenesin (API) Sales Breakdown by Type (2022-2027)
8.3 China Guaifenesin (API) Sales Breakdown by Application
8.3.1 China 318 Sales Breakdown by Application (2016-2021)
8.3.2 China 318 Sales Breakdown by Application (2022-2027)

9 Japan Guaifenesin (API) Market Facts & Figures
9.1 Japan Guaifenesin (API) Sales by Company
9.1.1 Japan Guaifenesin (API) Sales by Company (2016-2021)
9.1.2 Japan Guaifenesin (API) Revenue by Company (2016-2021)
9.2 Japan Guaifenesin (API) Sales Breakdown by Type
9.2.1 Japan Guaifenesin (API) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Guaifenesin (API) Sales Breakdown by Type (2022-2027)
9.3 Japan Guaifenesin (API) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Guaifenesin (API) Market Facts & Figures
10.1 Southeast Asia Guaifenesin (API) Sales by Company
10.1.1 Southeast Asia Guaifenesin (API) Sales by Company (2016-2021)
10.1.2 Southeast Asia Guaifenesin (API) Revenue by Company (2016-2021)
10.2 Southeast Asia Guaifenesin (API) Sales Breakdown by Type
10.2.1 Southeast Asia Guaifenesin (API) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Guaifenesin (API) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Guaifenesin (API) Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Guaifenesin (API) Market Facts & Figures
11.1 India Guaifenesin (API) Sales by Company
11.1.1 India Guaifenesin (API) Sales by Company (2016-2021)
11.1.2 India Guaifenesin (API) Revenue by Company (2016-2021)
11.2 India Guaifenesin (API) Sales Breakdown by Type
11.2.1 India Guaifenesin (API) Sales Breakdown by Type (2016-2021)
11.2.2 India Guaifenesin (API) Sales Breakdown by Type (2022-2027)
11.3 India Guaifenesin (API) Sales Breakdown by Application
11.3.1 India Guaifenesin (API) Sales Breakdown by Application (2016-2021)
11.3.2 India Guaifenesin (API) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Guaifenesin (API) Business
12.1 Granules
12.1.1 Granules Corporation Information
12.1.2 Granules Business Overview
12.1.3 Granules Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Granules Guaifenesin (API) Products Offered
12.1.5 Granules Recent Development
12.2 Synthokem Labs
12.2.1 Synthokem Labs Corporation Information
12.2.2 Synthokem Labs Business Overview
12.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Synthokem Labs Guaifenesin (API) Products Offered
12.2.5 Synthokem Labs Recent Development
12.3 Haizhou Pharma
12.3.1 Haizhou Pharma Corporation Information
12.3.2 Haizhou Pharma Business Overview
12.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Haizhou Pharma Guaifenesin (API) Products Offered
12.3.5 Haizhou Pharma Recent Development
12.4 Yuan Cheng Group
12.4.1 Yuan Cheng Group Corporation Information
12.4.2 Yuan Cheng Group Business Overview
12.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Yuan Cheng Group Guaifenesin (API) Products Offered
12.4.5 Yuan Cheng Group Recent Development
12.5 Stellar Chemical
12.5.1 Stellar Chemical Corporation Information
12.5.2 Stellar Chemical Business Overview
12.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Stellar Chemical Guaifenesin (API) Products Offered
12.5.5 Stellar Chemical Recent Development
12.6 Seven Star Pharma
12.6.1 Seven Star Pharma Corporation Information
12.6.2 Seven Star Pharma Business Overview
12.6.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Seven Star Pharma Guaifenesin (API) Products Offered
12.6.5 Seven Star Pharma Recent Development
12.7 Gennex Lab
12.7.1 Gennex Lab Corporation Information
12.7.2 Gennex Lab Business Overview
12.7.3 Gennex Lab Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Gennex Lab Guaifenesin (API) Products Offered
12.7.5 Gennex Lab Recent Development
12.8 Iwaki Seiyaku
12.8.1 Iwaki Seiyaku Corporation Information
12.8.2 Iwaki Seiyaku Business Overview
12.8.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Iwaki Seiyaku Guaifenesin (API) Products Offered
12.8.5 Iwaki Seiyaku Recent Development
12.9 Pan Drugs
12.9.1 Pan Drugs Corporation Information
12.9.2 Pan Drugs Business Overview
12.9.3 Pan Drugs Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pan Drugs Guaifenesin (API) Products Offered
12.9.5 Pan Drugs Recent Development
12.10 Delta Synthetic
12.10.1 Delta Synthetic Corporation Information
12.10.2 Delta Synthetic Business Overview
12.10.3 Delta Synthetic Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Delta Synthetic Guaifenesin (API) Products Offered
12.10.5 Delta Synthetic Recent Development
12.11 Smart Pharm
12.11.1 Smart Pharm Corporation Information
12.11.2 Smart Pharm Business Overview
12.11.3 Smart Pharm Guaifenesin (API) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Smart Pharm Guaifenesin (API) Products Offered
12.11.5 Smart Pharm Recent Development

13 Guaifenesin (API) Manufacturing Cost Analysis
13.1 Guaifenesin (API) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Guaifenesin (API)
13.4 Guaifenesin (API) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Guaifenesin (API) Distributors List
14.3 Guaifenesin (API) Customers

15 Market Dynamics
15.1 Guaifenesin (API) Market Trends
15.2 Guaifenesin (API) Drivers
15.3 Guaifenesin (API) Market Challenges
15.4 Guaifenesin (API) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Guaifenesin (API) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Guaifenesin (API) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Guaifenesin (API) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Guaifenesin (API) Sales (MT) by Region (2016-2021)
Table 5. Global Guaifenesin (API) Sales Market Share by Region (2016-2021)
Table 6. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Guaifenesin (API) Revenue Share by Region (2016-2021)
Table 8. Global Guaifenesin (API) Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Guaifenesin (API) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Guaifenesin (API) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Guaifenesin (API) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Guaifenesin (API) Sales (MT) of Key Companies (2016-2021)
Table 13. Global Guaifenesin (API) Sales Share by Company (2016-2021)
Table 14. Global Guaifenesin (API) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Guaifenesin (API) Revenue Share by Company (2016-2021)
Table 16. Global Guaifenesin (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guaifenesin (API) as of 2020)
Table 17. Global Guaifenesin (API) Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Guaifenesin (API) Manufacturing Sites and Area Served
Table 19. Manufacturers Guaifenesin (API) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Guaifenesin (API) Sales (MT) by Type (2016-2021)
Table 22. Global Guaifenesin (API) Sales Share by Type (2016-2021)
Table 23. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Guaifenesin (API) Price (USD/Kg) by Type (2016-2021)
Table 25. Global Guaifenesin (API) Sales Share by Type (2022-2027)
Table 26. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Guaifenesin (API) Revenue Share by Type (2022-2027)
Table 28. Global Guaifenesin (API) Price (USD/Kg) by Type (2022-2027)
Table 29. Global Guaifenesin (API) Sales (MT) by Application (2016-2021)
Table 30. Global Guaifenesin (API) Sales Share by Application (2016-2021)
Table 31. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Guaifenesin (API) Price (USD/Kg) by Application (2016-2021)
Table 33. Global Guaifenesin (API) Sales (MT) by Application (2022-2027)
Table 34. Global Guaifenesin (API) Sales Share by Application (2022-2027)
Table 35. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Guaifenesin (API) Revenue Share by Application (2022-2027)
Table 37. Global Guaifenesin (API) Price (USD/Kg) by Application (2022-2027)
Table 38. North America Guaifenesin (API) Sales (MT) by Company (2016-2021)
Table 39. North America Guaifenesin (API) Sales Market Share by Company (2016-2021)
Table 40. North America Guaifenesin (API) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Guaifenesin (API) Revenue Market Share by Company (2016-2021)
Table 42. North America Guaifenesin (API) Sales by Type (2016-2021) & (MT)
Table 43. North America Guaifenesin (API) Sales Market Share by Type (2016-2021)
Table 44. North America Guaifenesin (API) Sales by Type (2022-2027) & (MT)
Table 45. North America Guaifenesin (API) Sales Market Share by Type (2022-2027)
Table 46. North America Guaifenesin (API) Sales by Application (2016-2021) & (MT)
Table 47. North America Guaifenesin (API) Sales Market Share by Application (2016-2021)
Table 48. North America Guaifenesin (API) Sales by Application (2022-2027) & (MT)
Table 49. North America Guaifenesin (API) Sales Market Share by Application (2022-2027)
Table 50. Europe Guaifenesin (API) Sales (MT) by Company (2016-2021)
Table 51. Europe Guaifenesin (API) Sales Market Share by Company (2016-2021)
Table 52. Europe Guaifenesin (API) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Guaifenesin (API) Revenue Market Share by Company (2016-2021)
Table 54. Europe Guaifenesin (API) Sales by Type (2016-2021) & (MT)
Table 55. Europe Guaifenesin (API) Sales Market Share by Type (2016-2021)
Table 56. Europe Guaifenesin (API) Sales by Type (2022-2027) & (MT)
Table 57. Europe Guaifenesin (API) Sales Market Share by Type (2022-2027)
Table 58. Europe Guaifenesin (API) Sales by Application (2016-2021) & (MT)
Table 59. Europe Guaifenesin (API) Sales Market Share by Application (2016-2021)
Table 60. Europe Guaifenesin (API) Sales by Application (2022-2027) & (MT)
Table 61. Europe Guaifenesin (API) Sales Market Share by Application (2022-2027)
Table 62. China Guaifenesin (API) Sales (MT) by Company (2016-2021)
Table 63. China Guaifenesin (API) Sales Market Share by Company (2016-2021)
Table 64. China Guaifenesin (API) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Guaifenesin (API) Revenue Market Share by Company (2016-2021)
Table 66. China Guaifenesin (API) Sales by Type (2016-2021) & (MT)
Table 67. China Guaifenesin (API) Sales Market Share by Type (2016-2021)
Table 68. China Guaifenesin (API) Sales by Type (2022-2027) & (MT)
Table 69. China Guaifenesin (API) Sales Market Share by Type (2022-2027)
Table 70. China Guaifenesin (API) Sales by Application (2016-2021) & (MT)
Table 71. China Guaifenesin (API) Sales Market Share by Application (2016-2021)
Table 72. China Guaifenesin (API) Sales by Application (2022-2027) & (MT)
Table 73. China Guaifenesin (API) Sales Market Share by Application (2022-2027)
Table 74. Japan Guaifenesin (API) Sales (MT) by Company (2016-2021)
Table 75. Japan Guaifenesin (API) Sales Market Share by Company (2016-2021)
Table 76. Japan Guaifenesin (API) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Guaifenesin (API) Revenue Market Share by Company (2016-2021)
Table 78. Japan Guaifenesin (API) Sales by Type (2016-2021) & (MT)
Table 79. Japan Guaifenesin (API) Sales Market Share by Type (2016-2021)
Table 80. Japan Guaifenesin (API) Sales by Type (2022-2027) & (MT)
Table 81. Japan Guaifenesin (API) Sales Market Share by Type (2022-2027)
Table 82. Japan Guaifenesin (API) Sales by Application (2016-2021) & (MT)
Table 83. Japan Guaifenesin (API) Sales Market Share by Application (2016-2021)
Table 84. Japan Guaifenesin (API) Sales by Application (2022-2027) & (MT)
Table 85. Japan Guaifenesin (API) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Guaifenesin (API) Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Guaifenesin (API) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Guaifenesin (API) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Guaifenesin (API) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Guaifenesin (API) Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Guaifenesin (API) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Guaifenesin (API) Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Guaifenesin (API) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Guaifenesin (API) Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Guaifenesin (API) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Guaifenesin (API) Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Guaifenesin (API) Sales Market Share by Application (2022-2027)
Table 98. India Guaifenesin (API) Sales (MT) by Company (2016-2021)
Table 99. India Guaifenesin (API) Sales Market Share by Company (2016-2021)
Table 100. India Guaifenesin (API) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Guaifenesin (API) Revenue Market Share by Company (2016-2021)
Table 102. India Guaifenesin (API) Sales by Type (2016-2021) & (MT)
Table 103. India Guaifenesin (API) Sales Market Share by Type (2016-2021)
Table 104. India Guaifenesin (API) Sales by Type (2022-2027) & (MT)
Table 105. India Guaifenesin (API) Sales Market Share by Type (2022-2027)
Table 106. India Guaifenesin (API) Sales by Application (2016-2021) & (MT)
Table 107. India Guaifenesin (API) Sales Market Share by Application (2016-2021)
Table 108. India Guaifenesin (API) Sales by Application (2022-2027) & (MT)
Table 109. India Guaifenesin (API) Sales Market Share by Application (2022-2027)
Table 110. Granules Corporation Information
Table 111. Granules Description and Business Overview
Table 112. Granules Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Granules Guaifenesin (API) Product
Table 114. Granules Recent Development
Table 115. Synthokem Labs Corporation Information
Table 116. Synthokem Labs Description and Business Overview
Table 117. Synthokem Labs Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Synthokem Labs Guaifenesin (API) Product
Table 119. Synthokem Labs Recent Development
Table 120. Haizhou Pharma Corporation Information
Table 121. Haizhou Pharma Description and Business Overview
Table 122. Haizhou Pharma Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Haizhou Pharma Guaifenesin (API) Product
Table 124. Haizhou Pharma Recent Development
Table 125. Yuan Cheng Group Corporation Information
Table 126. Yuan Cheng Group Description and Business Overview
Table 127. Yuan Cheng Group Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Yuan Cheng Group Guaifenesin (API) Product
Table 129. Yuan Cheng Group Recent Development
Table 130. Stellar Chemical Corporation Information
Table 131. Stellar Chemical Description and Business Overview
Table 132. Stellar Chemical Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Stellar Chemical Guaifenesin (API) Product
Table 134. Stellar Chemical Recent Development
Table 135. Seven Star Pharma Corporation Information
Table 136. Seven Star Pharma Description and Business Overview
Table 137. Seven Star Pharma Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Seven Star Pharma Guaifenesin (API) Product
Table 139. Seven Star Pharma Recent Development
Table 140. Gennex Lab Corporation Information
Table 141. Gennex Lab Description and Business Overview
Table 142. Gennex Lab Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Gennex Lab Guaifenesin (API) Product
Table 144. Gennex Lab Recent Development
Table 145. Iwaki Seiyaku Corporation Information
Table 146. Iwaki Seiyaku Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Iwaki Seiyaku Description and Business Overview
Table 148. Iwaki Seiyaku Guaifenesin (API) Product
Table 149. Iwaki Seiyaku Recent Development
Table 150. Pan Drugs Corporation Information
Table 151. Pan Drugs Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. Pan Drugs Description and Business Overview
Table 153. Pan Drugs Guaifenesin (API) Product
Table 154. Pan Drugs Recent Development
Table 155. Delta Synthetic Corporation Information
Table 156. Delta Synthetic Description and Business Overview
Table 157. Delta Synthetic Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Delta Synthetic Guaifenesin (API) Product
Table 159. Delta Synthetic Recent Development
Table 160. Smart Pharm Corporation Information
Table 161. Smart Pharm Description and Business Overview
Table 162. Smart Pharm Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. Smart Pharm Guaifenesin (API) Product
Table 164. Smart Pharm Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Guaifenesin (API) Distributors List
Table 168. Guaifenesin (API) Customers List
Table 169. Guaifenesin (API) Market Trends
Table 170. Guaifenesin (API) Market Drivers
Table 171. Guaifenesin (API) Market Challenges
Table 172. Guaifenesin (API) Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Guaifenesin (API) Product Picture
Figure 2. Global Guaifenesin (API) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Guaifenesin (API) Sales Market Share by Application in 2021 & 2027
Figure 6. Pharmaceuticals Examples
Figure 7. Others Examples
Figure 8. Global Guaifenesin (API) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Guaifenesin (API) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Guaifenesin (API) Sales (MT) Growth Rate (2016-2027)
Figure 11. Global Guaifenesin (API) Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 12. Global Guaifenesin (API) Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Guaifenesin (API) Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Guaifenesin (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Guaifenesin (API) Sales (MT) Growth Rate (2016-2027)
Figure 16. Europe Guaifenesin (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Guaifenesin (API) Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Guaifenesin (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Guaifenesin (API) Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Guaifenesin (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Guaifenesin (API) Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Guaifenesin (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Guaifenesin (API) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Guaifenesin (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Guaifenesin (API) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Guaifenesin (API) Players Market Share by Revenue in Guaifenesin (API): 2016 & 2020
Figure 27. Guaifenesin (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Guaifenesin (API) Revenue Share by Type (2016-2021)
Figure 29. Global Guaifenesin (API) Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Guaifenesin (API) Revenue Share by Application (2016-2021)
Figure 31. Global Guaifenesin (API) Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Guaifenesin (API) Sales Market Share by Type in 2020
Figure 33. North America Guaifenesin (API) Sales Market Share by Application in 2020
Figure 34. Europe Guaifenesin (API) Sales Market Share by Type in 2020
Figure 35. Europe Guaifenesin (API) Sales Market Share by Application in 2020
Figure 36. China Guaifenesin (API) Sales Market Share by Type in 2020
Figure 37. China Guaifenesin (API) Sales Market Share by Application in 2020
Figure 38. Japan Guaifenesin (API) Sales Market Share by Type in 2020
Figure 39. Japan Guaifenesin (API) Sales Market Share by Application in 2020
Figure 40. Southeast Asia Guaifenesin (API) Sales Market Share by Type in 2020
Figure 41. Southeast Asia Guaifenesin (API) Sales Market Share by Application in 2020
Figure 42. India Guaifenesin (API) Sales Market Share by Type in 2020
Figure 43. India Guaifenesin (API) Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Guaifenesin (API)
Figure 46. Manufacturing Process Analysis of Guaifenesin (API)
Figure 47. Guaifenesin (API) Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

以下、関連資料のご紹介

グアイフェネシンのグローバル市場調査 2019年

Global Guaifenesin Market Professional Survey Report 2019
QYR9NV05679 2019年11月12日 111Pages
※本調査レポートは、グアイフェネシンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、98％-99％、> 99％に、用途別には、医薬品、パーソナルケア製品、その...

トラゾドン塩酸塩（API）のグローバル市場2021

Global Trazodone Hydrochloride (API) Sales Market Report 2021
QAF27488 2021年4月2日 132Pages
本市場調査資料では、世界のトラゾドン塩酸塩（API）市場について種類別（トラゾドン塩酸塩（API）、その他）、用途別（抗うつ薬、抗不安薬、催眠薬、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、...

生体吸収性スキャフォールド（BVS）のグローバル市場2021

Global Bioresorbable Vascular Scaffold Sales Market Report 2021
QAF27590 2021年4月13日 138Pages
本市場調査資料では、世界の生体吸収性スキャフォールド（BVS）市場について種類別（金属BVS、ポリマーBVS）、用途別（病院＆クリニック、医療センター）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売...

抗体薬物複合体（ADC）のグローバル市場2021

Global Antibody-drug Conjugates Sales Market Report 2021
QAF27563 2021年3月23日 131Pages
本市場調査資料では、世界の抗体薬物複合体（ADC）市場について種類別（アドセトリス、カドサイラ）、用途別（乳がん、リンパ腫）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの...

DNAシークエンシングのグローバル市場2021

Global DNA Sequencing Sales Market Report 2021
QAF27115 2021年4月21日 136Pages
本市場調査資料では、世界のDNAシークエンシング市場について種類別（第1世代DNAシーケンス、第2世代DNAシーケンス、第3世代DNAシーケンス）、用途別（オンコロジーDNAシーケンシング、ライフサイエンスDNAシーケンシング、新アプリケーションDNAシーケンシング、遺伝性疾患検出DNAシーケンシ...

大動脈内バルーンポンプ(IABP)のグローバル市場2021

Global Intra-Aortic Balloon Pump (IABP) Sales Market Report 2021
QAF27235 2021年3月24日 138Pages
本市場調査資料では、世界の大動脈内バルーンポンプ(IABP)市場について種類別（光ファイバータイプ、一般タイプ）、用途別（病院、心臓病センター、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売...

ビタミンB1（チアミン一硝酸塩）のグローバル市場2021

Global Vitamin B1 (Thiamine Mononitrate) Sales Market Report 2021
QAF27935 2021年4月8日 137Pages
本市場調査資料では、世界のビタミンB1（チアミン一硝酸塩）市場について種類別（硝酸チアミンタイプ、塩酸チアミンタイプ）、用途別（飼料添加物、食品添加物、医薬品、サプリメント、化粧品）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年ま...

上皮成長因子（EGF）のグローバル市場2021

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Report 2021
QAF27671 2021年4月13日 131Pages
本市場調査資料では、世界の上皮成長因子（EGF）市場について種類別（液体、粉末）、用途別（EGFクリーム、EGFローション、EGFマスク、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価...

フェニルケトン尿症（PKU）のグローバル市場2021

Global Phenylketonuria (PKU) Sales Market Report 2021
QAF27838 2021年3月31日 145Pages
本市場調査資料では、世界のフェニルケトン尿症（PKU）市場について種類別（医薬品、サプリメント、その他）、用途別（家庭用、病院）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤ...

小角X線散乱（SAXS）のグローバル市場2021

Global Small Angle X-ray Scattering (SAXS) Sales Market Report 2021
QAF27436 2021年4月14日 139Pages
本市場調査資料では、世界の小角X線散乱（SAXS）市場について種類別（クローズドタイプ、セグメントタイプ）、用途別（研究所、大学）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイ...

グアイフェネシンのグローバル市場調査 2019年 The global Guaifenesin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Guaifenesin volume and value at global level, regional level and company level. From a global perspective, this report represen…
過敏性腸症候群（IBS）のグローバル市場2021 Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predomin…
ビタミンB2（リボフラビン）のグローバル市場2021 The Riboflavin, also known as vitamin B2, is a vitamin found in food and used as a dietary supplement. As a supplement it is used to prevent and treat riboflavin deficiency and prevent migraines. It can be used as a therapeutic mouth, eyes and genital inflammation APIs. Riboflavin application is ver…
医薬品包装のグローバル市場2021 Pharmaceutical Packaging is the packages used for medicine. It includes glass packaging, plastic packaging, aluminum foil packaging, and other pharmaceutical packaging. And applications of pharmaceuticals packaging are oral drugs, injectable and other areas. The sale of India pharmaceutical packagin…
ポリアミド46（PA 46ナイロン46）のグローバル市場2021 Polyamide 46 (PA 46 Nylon 46) is a high heat resistant polyamide or nylon. DSM is the only commercial supplier of this resin, which markets under the trade name Stanyl. DSM occupied 80% global Polyamide 46 market share. Market Analysis and Insights: Global Polyamide 46 (PA 46 Nylon 46) Market The gl…